Martin Shkreli Violated Lifetime Ban From Drug Industry, U.S. Says NYT - Home Page By: Ashley Southall 13 October 2026 at 18:48 The attorneys general of New York and six other states joined the Federal Trade Commission in accusing the disgraced former pharmaceutical executive of repeatedly violating the ban. © Sam Hodgson for The New York TimesMartin Shkreli was convicted in 2022 of engaging in anticompetitive behavior when he significantly raised the price of the drug Daraprim.
Login
